Title: Hypoxia-Inducible Factor-la (HIF-l alpha) Potentiates beta-Cell Survival After Islet Transplantation of Human and Mouse Islets
Authors: Stokes, RA
Cheng, K
Deters, N
Lau, SM
Hawthorne, WJ
O’Connell, PJ
Stolp, J
Grey, S
Loudovaris, T
Kay, TW
Thomas, HE
Gonzalez, FJ
Gunton, JE
Issue Year: 2013
Publisher COGNIZANT COMMUNICATION CORP
Series CELL TRANSPLANTATION: 22(2): 253-266
Abstract A high proportion of beta-cells die within days of islet transplantation. Reports suggest that induction of hypoxia-inducible factor-l alpha (HIF-1 alpha) predicts adverse transplant outcomes. We hypothesized that this was a compensatory response and that HIF-l alpha protects beta-cells during transplantation. Transplants were performed using human islets or murine beta-cell-specific HIP-la-null (beta-HIP-1 alpha-null) islets with or without treatment with deferoxamine (DFO) to increase HIF-l alpha. beta-HIF-1 alpha-null transplants had poor outcomes, demonstrating that lack of HIP-l alpha impaired transplant efficiency. Increasing HIP-la improved outcomes for mouse and human islets. No effect was seen in beta-HIF-l alpha-null islets. The mechanism was decreased apoptosis, resulting in increased beta-cell mass posttransplantation. These findings show that HIP-1 alpha is a protective factor and is required for successful islet transplant outcomes. Iron chelation with DFO markedly improved transplant success in a HIPl alpha-dependent manner, thus demonstrating the mechanism of action. DFO, approved for human use, may have a therapeutic role in the setting of human islet transplantation.
URI: https://publications.svi.edu.au/publications/1669
Other Identifiers 10.3727/096368912X647180
Publication type Article
Grant ID GNT0516700; GNT0620232
Find it online http://www.ingentaconnect.com/content/cog/ct/2013/00000022/00000002/art00005?token=005116095d62a96e586546243142423b47792176703424705e4e26634a492f25303329761657a62db